Loomis Sayles & Company LP Stake In Novo (NVO) Was Raised

Annette Crawford
March 13, 2018

Ballentine Partners Llc bought 2,178 shares as the company's stock rose 10.88% with the market. The Carnegie Capital Asset Management Llc holds 116,760 shares with $5.86 million value, down from 122,869 last quarter. Netease Inc now has $41.02B valuation. SUSMAN SALLY sold $1.34M worth of stock or 38,230 shares. Facebook, Inc. (NASDAQ:FB) has risen 26.75% since March 8, 2017 and is uptrending.

Carnegie Capital Asset Management Llc decreased Novo (NVO) stake by 4.97% reported in 2017Q3 SEC filing. Guardian Capital Lp acquired 9,475 shares as Novo (NVO)'s stock rose 15.20%. Zions Bancorporation now owns 2,852 shares of the company's stock valued at $137,000 after buying an additional 2,485 shares in the last quarter. Amg Funds Llc who had been investing in Novo for a number of months, seems to be less bullish one the $121.92 billion market cap company.

Novo Nordisk A/S (NYSE:NVO) traded down $0.15 during trading hours on Friday, reaching $50.87. About 1.08 million shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since March 11, 2017 and is downtrending. It has underperformed by 40.63% the S&P500.

Investors sentiment increased to 0.96 in Q3 2017. Its up 0.19, from 0.95 in 2017Q2. (NASDAQ:ABMD) or 51 shares. Renaissance Tech Llc holds 82,900 shares or 0.01% of its portfolio. Zpr Investment Management owns 4,992 shares or 0.35% of their USA portfolio. Los Angeles And Equity Research Inc holds 2.49% in Facebook, Inc. NVO's total short interest was 2.32M shares in March as published by FINRA. Invest House Limited Liability Company reported 0.09% in ABIOMED, Inc. Texas Permanent School Fund owns 43,581 shares. Spc, Maryland-based fund reported 5,371 shares. Addenda Capital Inc. acquired a new position in Novo Nordisk A/S in the fourth quarter valued at $201,000. 239,575 are owned by Champlain Prtn Limited Liability Corp.

Eidelman Virant Capital holds 1.15% of its portfolio in Salisbury Bancorp, Inc. for 41,724 shares. Metropolitan Life Insurance Co stated it has 0.01% in Actuant Corporation (NYSE:ATU). Cleararc Incorporated reported 17,296 shares. The Georgia-based Caldwell & Orkin has invested 3.41% in The Home Depot, Inc. The SI to RAKUTEN INC ORDINARY SHARES's float is 1.4%.


Since February 21, 2018, it had 2 buys, and 0 selling transactions for $20.00 million activity. Folketrygdfondet now owns 7,217,043 shares of the company's stock valued at $347,501,000 after acquiring an additional 302,851 shares during the period. 750 shares valued at $129,325 were sold by Stretch Colin on Tuesday, October 24.

Novo Nordisk A/S declared that its Board of Directors has approved a share buyback plan on Thursday, February 1st that permits the company to repurchase shares. (NASDAQ:FB) on Friday, September 29. Morgan Stanley upgraded the stock to "Overweight" rating in Friday, December 1 report. Therefore 93% are positive. Developers Diversified Realty had 61 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was downgraded by Citigroup on Monday, October 31 to "Neutral". The firm has "Buy" rating given on Wednesday, December 6 by Bank of America. JP Morgan maintained the stock with "Overweight" rating in Thursday, February 25 report. The stock of Honeywell International Inc. As per Thursday, April 6, the company rating was upgraded by PiperJaffray. The rating was maintained by Credit Suisse with "Outperform" on Monday, December 7. The firm earned "Hold" rating on Monday, October 31 by DNB Markets. The company was upgraded on Friday, August 28 by Zacks. The company has an average rating of "Hold" and an average target price of $64.00. It also reduced its holding in Wisdomtree Emerging Markets (DEM) by 8,175 shares in the quarter, leaving it with 12,175 shares, and cut its stake in Dunkin' Brands Group Inc (NASDAQ:DNKN). Zacks Investment Research raised Novo Nordisk A/S from a "hold" rating to a "buy" rating and set a $64.00 price objective on the stock in a report on Friday, January 26th. Therefore 47% are positive. The stock of Novo Nordisk A/S (NYSE:NVO) earned "Outperform" rating by BNP Paribas on Tuesday, September 13. Bank of America raised shares of Novo Nordisk A/S from a "neutral" rating to a "buy" rating in a research report on Wednesday, December 6th. The rating was downgraded by Morgan Stanley to "Equal-Weight" on Thursday, September 1. Jefferies maintained it with "Hold" rating and $345.0 target in Monday, December 18 report. Piper Jaffray initiated the shares of NVO in report on Friday, September 23 with "Neutral" rating. As per Monday, February 8, the company rating was downgraded by UBS. The stock of Novo Nordisk A/S (NYSE:NVO) earned "Buy" rating by Goldman Sachs on Friday, January 19.

Analysts await MetLife, Inc. They expect $0.70 earnings per share, up 1.45% or $0.01 from last year's $0.69 per share. MET's profit will be $1.23 billion for 9.84 P/E if the $1.19 EPS becomes a reality. Parsec Financial Management Inc. grew its stake in shares of Novo Nordisk A/S by 0.3% during the 4th quarter.

Flow Traders Us Llc, which manages about $928.44 million US Long portfolio, decreased its stake in Ishares Msci Eurozone Etf (EZU) by 766,809 shares to 177,721 shares, valued at $7.70M in 2017Q3, according to the filing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER